Sandoz agreed to pay $478.5 million to settle allegations that the company engaged in a conspiracy to artificially inflate and manipulate prices.

Sandoz pagará US$ 450 milhões para encerrar litígios antitruste nos EUA

Swiss pharma firm Sandoz will pay $478.5M to settle US generic drug price-fixing claims while denying wrongdoing.